Clinical Practice Recommendations for Pediatric Dyslipidemia
The leading cause of mortality in the United States is atherosclerotic cardiovascular disease (ASCVD). Atherosclerotic lesions begin during childhood and can place individuals at greater risk for ASCVD. Providers play an active role in preventing the progression of risk factors and future ASCVD events through appropriate clinical management of genetic and acquired dyslipidemias in the pediatric population. Health care providers need to be aware of current recommendations related to screening for dyslipidemia, lifestyle modification strategies, pharmacologic treatment, and guidelines for ongoing monitoring.
Source: Journal of Pediatric Health Care - Category: Pediatrics Authors: Casey Elkins, Sharon Fruh, Loretta Jones, Katherine Bydalek Tags: Continuing Education Source Type: research
More News: Cardiology | Cardiovascular | Education | Genetics | Health Management | Heart | Pediatrics | Universities & Medical Training | USA Health